More Company News

Arecor Therapeutics

Interim H123 results
14 Sep 2023Read More

Arecor Therapeutics

AT307 positive FDA pre-IND meeting
07 Sep 2023Read More

Arecor Therapeutics

Tetris Pharma collaboration with Goodlife
04 Sep 2023Read More

Arecor Therapeutics

Collaboration with top 10 global pharma
17 Aug 2023Read More

Arecor Therapeutics

H123 business update
20 Jul 2023Read More

Arecor Therapeutics

Additional agreement with leading biopharma
05 Jul 2023Read More

Arecor Therapeutics

Key patents granted in Europe & China
27 Jun 2023Read More

Arecor Therapeutics

Positive AT247 data presented at ADA
26 Jun 2023Read More

Arecor Therapeutics

Tetris Pharma launches Ogluo in Denmark & Norway
15 May 2023Read More

Arecor Therapeutics

US patent grant protecting proprietary mAb formulations
26 Apr 2023Read More

1 2 3 4 … 6
Return to Arecor Therapeutics
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).